Skip to main content
. 2009 Jan 14;296(3):F505–F511. doi: 10.1152/ajprenal.90545.2008

Fig. 2.

Fig. 2.

Ctr1 expression renal cells and tissues during cisplatin treatment. A: HEK293 and renal proximal tubule cells (RPTC) cells were treated with 20 and 40 μM cisplatin, respectively, for indicated time points, and whole-cell lysates were collected and used for immunoblot analysis of Ctr1. B: male C57BL/6 mice were treated with 30 mg/kg cisplatin, and kidney lysates were prepared on days 0, 1, 2, and 3 for immunoblot analysis of Ctr1.

HHS Vulnerability Disclosure